AU2001253456A1 - Antithrombogenic membrane mimetic compositions and methods - Google Patents

Antithrombogenic membrane mimetic compositions and methods

Info

Publication number
AU2001253456A1
AU2001253456A1 AU2001253456A AU5345601A AU2001253456A1 AU 2001253456 A1 AU2001253456 A1 AU 2001253456A1 AU 2001253456 A AU2001253456 A AU 2001253456A AU 5345601 A AU5345601 A AU 5345601A AU 2001253456 A1 AU2001253456 A1 AU 2001253456A1
Authority
AU
Australia
Prior art keywords
antithrombogenic
methods
mimetic compositions
membrane mimetic
membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001253456A
Inventor
Elliot L Chaikof
June Feng
Hongbo Liu
Janine M. Orban
Xue-Long Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emory University
Original Assignee
Emory University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emory University filed Critical Emory University
Publication of AU2001253456A1 publication Critical patent/AU2001253456A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/222—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0076—Chemical modification of the substrate
    • A61L33/0082—Chemical modification of the substrate by reacting with an organic compound other than heparin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A61L33/12—Polypeptides, proteins or derivatives thereof, e.g. degradation products thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65525—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a seven-(or more) membered ring
AU2001253456A 2000-04-13 2001-04-13 Antithrombogenic membrane mimetic compositions and methods Abandoned AU2001253456A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US19707200P 2000-04-13 2000-04-13
US60197072 2000-04-13
US22161800P 2000-07-28 2000-07-28
US60221618 2000-07-28
PCT/US2001/012094 WO2001078800A1 (en) 2000-04-13 2001-04-13 Antithrombogenic membrane mimetic compositions and methods

Publications (1)

Publication Number Publication Date
AU2001253456A1 true AU2001253456A1 (en) 2001-10-30

Family

ID=26892522

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001253456A Abandoned AU2001253456A1 (en) 2000-04-13 2001-04-13 Antithrombogenic membrane mimetic compositions and methods

Country Status (6)

Country Link
US (1) US6936298B2 (en)
EP (1) EP1272237A1 (en)
JP (1) JP2004511267A (en)
AU (1) AU2001253456A1 (en)
CA (1) CA2406343A1 (en)
WO (1) WO2001078800A1 (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004511267A (en) 2000-04-13 2004-04-15 エモリー・ユニバーシティ Antithrombogenic membrane mimetic compositions and methods
US7713544B2 (en) * 2000-07-28 2010-05-11 Emory University Biological component comprising artificial membrane
GB0100761D0 (en) 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
US7244830B2 (en) 2001-01-12 2007-07-17 Emory University Glycopolymers and free radical polymerization methods
WO2002092201A2 (en) * 2001-05-11 2002-11-21 Poly-An Gesellschaft zur Herstellung von Polymeren für spezielle Anwendungen und Analytik mbH Method for reducing an adsorption tendency of molecules or biological cells on a material surface
TW200304385A (en) * 2002-03-13 2003-10-01 Novartis Ag Materials containing multiple layers of vesicles
US20050180945A1 (en) * 2002-05-21 2005-08-18 Chaikof Elliot L. Multivalent polymers with chan-terminating binding groups
US7208089B2 (en) * 2002-07-29 2007-04-24 Mt Technologies, Inc. Biomimetic membranes
US7833978B2 (en) 2004-02-20 2010-11-16 Emory University Thrombomodulin derivatives and conjugates
US20050208093A1 (en) 2004-03-22 2005-09-22 Thierry Glauser Phosphoryl choline coating compositions
US7824672B2 (en) * 2004-03-26 2010-11-02 Emory University Method for coating living cells
CN101238142B (en) * 2005-02-18 2012-11-14 国立大学法人德岛大学 Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative
US20090123516A1 (en) * 2005-08-08 2009-05-14 The Board Of Regents Of The University Of Texas System Drug delivery from implants using self-assembled monolayers-therapeutic sams
US20070067882A1 (en) * 2005-09-21 2007-03-22 Liliana Atanasoska Internal medical devices having polyelectrolyte-containing extruded regions
US7708774B1 (en) 2005-11-16 2010-05-04 Pacesetter, Inc. Polyethylene oxide and silicone copolymers and their usage on medical devices
US7715922B1 (en) 2005-11-16 2010-05-11 Pacesetter, Inc. Polyethylene oxide and polyisobutylene copolymers and their usage on medical devices
US7553546B1 (en) 2005-11-16 2009-06-30 Pacesetter, Inc. Polyethylene oxide and silicone copolymers and their usage on medical devices
US8354134B2 (en) * 2005-12-22 2013-01-15 Cargill, Incorporated Rheologically balanced high fiber ingredient for food products
WO2008033847A2 (en) 2006-09-11 2008-03-20 Emory University Modified protein polymers
US20090319020A1 (en) * 2007-01-23 2009-12-24 Dtherapeutics, Llc Devices, systems, and methods for promoting endothelialization
DE102007044648B4 (en) * 2007-09-18 2020-11-26 Carl Freudenberg Kg Bioresorbable gelatin non-woven fabric
US8795577B2 (en) 2007-11-30 2014-08-05 Cook Medical Technologies Llc Needle-to-needle electrospinning
US7799261B2 (en) * 2007-11-30 2010-09-21 Cook Incorporated Needle-to-needle electrospinning
US20100209475A1 (en) * 2009-02-19 2010-08-19 Biomet Manufacturing Corp. Medical implants having a drug delivery coating
JP2012522782A (en) * 2009-04-03 2012-09-27 ザ・ユニバーシティ・オブ・トレド PEG-albumin composition having at least one protected thiol region as a platform for medicine
US8637109B2 (en) * 2009-12-03 2014-01-28 Cook Medical Technologies Llc Manufacturing methods for covering endoluminal prostheses
WO2011109447A1 (en) * 2010-03-02 2011-09-09 University Of Rochester Implantable devices that generate low intensity electric fields for the treatment of atherosclerotic disease and prevention of ischemic vascular events and methods of manufacture
CN103703085B (en) 2011-01-19 2016-09-28 哈佛学院院长等 Smooth fluid injection porous surface and its biological applications
US9353646B2 (en) 2011-01-19 2016-05-31 President And Fellows Of Harvard College Slippery surfaces with high pressure stability, optical transparency, and self-healing characteristics
US9175427B2 (en) 2011-11-14 2015-11-03 Cook Medical Technologies Llc Electrospun patterned stent graft covering
KR102300462B1 (en) 2012-07-12 2021-09-08 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Slippery self-lubricating polymer surfaces
CN104769049A (en) 2012-07-13 2015-07-08 哈佛学院 Multifunctional repellent materials
US9630224B2 (en) 2012-07-13 2017-04-25 President And Fellows Of Harvard College Slippery liquid-infused porous surfaces having improved stability
CN103087090B (en) * 2012-12-18 2015-07-22 深圳万乐药业有限公司 Synthetic method of 2-dipalmitoyl-sn-glycero-3-phosphoethanolamine
US10154918B2 (en) 2012-12-28 2018-12-18 Cook Medical Technologies Llc Endoluminal prosthesis with fiber matrix
EP2969258A4 (en) 2013-03-13 2016-11-30 Harvard College Solidifiable composition for preparation of liquid-infused slippery surfaces and methods of applying
US9545301B2 (en) 2013-03-15 2017-01-17 Covidien Lp Coated medical devices and methods of making and using same
US9668890B2 (en) 2013-11-22 2017-06-06 Covidien Lp Anti-thrombogenic medical devices and methods
CN104628552A (en) * 2015-02-09 2015-05-20 许昌豪丰化学科技有限公司 New quenching system and application thereof
WO2019210296A1 (en) * 2018-04-27 2019-10-31 Karma Biotechnologies Multi-vesicular liposomes for targeted delivery of drugs and biologics for tissue engineering
CN113069598B (en) * 2020-01-06 2022-05-17 中国科学院宁波材料技术与工程研究所 Anticoagulation modification method of hemodialyzer
CN114028623B (en) * 2021-10-26 2024-02-27 江苏朴芃医疗科技有限公司 Cardiac shunt
CN115246910A (en) * 2022-04-29 2022-10-28 上海微密医疗科技有限公司 Synthesis method and application of polymer

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4522803A (en) 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
US4560599A (en) 1984-02-13 1985-12-24 Marquette University Assembling multilayers of polymerizable surfactant on a surface of a solid material
MX9203291A (en) 1985-06-26 1992-08-01 Liposome Co Inc LIPOSOMAS COUPLING METHOD.
US5755788A (en) 1987-02-19 1998-05-26 Rutgers, The State University Prosthesis and implants having liposomes bound thereto and methods of preparation
US4880883A (en) 1987-06-03 1989-11-14 Wisconsin Alumni Research Foundation Biocompatible polyurethanes modified with lower alkyl sulfonate and lower alkyl carboxylate
US4906465A (en) 1987-10-19 1990-03-06 Massachusetts Institute Of Technology Antithrombogenic devices containing polysiloxanes
US5288517A (en) 1988-08-26 1994-02-22 Canon Kabushiki Kaisha Method of forming planar membrane
FR2640955B1 (en) 1988-12-26 1991-11-29 Taillet Joseph
US5098437A (en) * 1991-02-13 1992-03-24 Pfizer Hospital Products Group, Inc. Acetabular cup positioning insert
JP3376591B2 (en) * 1991-08-28 2003-02-10 三菱ウェルファーマ株式会社 Protein C activation promoter
WO1993005825A1 (en) 1991-09-20 1993-04-01 Baxter International Inc. Processes for reducing the thrombogenicity of biomaterials
EP0597593A1 (en) 1992-10-30 1994-05-18 Medtronic, Inc. Thromboresistant articles
WO1995009586A1 (en) 1993-10-01 1995-04-13 Emory University Self-expanding intraluminal composite prosthesis
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
US5911942A (en) 1995-11-02 1999-06-15 Tissue Engineering, Inc. Method for spinning and processing collagen fiber
US5822517A (en) * 1996-04-15 1998-10-13 Dotan; Eyal Method for detecting infection of software programs by memory resident software viruses
US6071532A (en) * 1996-10-15 2000-06-06 Emory University Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof
US6583251B1 (en) * 1997-09-08 2003-06-24 Emory University Modular cytomimetic biomaterials, transport studies, preparation and utilization thereof
CA2310573A1 (en) 1998-06-30 2000-01-06 John H. Chon Modular cytomimetic biomaterials, transport studies, preparation and utilization thereof
JP2004511267A (en) 2000-04-13 2004-04-15 エモリー・ユニバーシティ Antithrombogenic membrane mimetic compositions and methods
AU2001255544A1 (en) 2000-04-20 2001-11-07 Emory University Native protein mimetic fibers, fiber networks and fabrics for medical use
US7713544B2 (en) * 2000-07-28 2010-05-11 Emory University Biological component comprising artificial membrane
US7244830B2 (en) 2001-01-12 2007-07-17 Emory University Glycopolymers and free radical polymerization methods

Also Published As

Publication number Publication date
JP2004511267A (en) 2004-04-15
CA2406343A1 (en) 2001-10-25
US6936298B2 (en) 2005-08-30
EP1272237A1 (en) 2003-01-08
WO2001078800A1 (en) 2001-10-25
US20040073295A1 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
AU2001253456A1 (en) Antithrombogenic membrane mimetic compositions and methods
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2778801A (en) Antisense compositions and methods
AU2001294093A1 (en) Techniques for hiding network element names and addresses
AU2001260327A1 (en) Chair
AU2002216063A1 (en) Membrane molecule indicator compositions and methods
AU2001250875A1 (en) Anti-microbial and immunostimulating composition
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2001280599A1 (en) Compounds and methods
AU2001265125A1 (en) Audience attention and response evaluation
AU2002211717A1 (en) Stresscopins and their uses
AU2001272011A1 (en) Siderophores-producing bifidobacteria thereby and uses thereof
AU2002241508A1 (en) Membrane derived caspase-3, compositions comprising the same and methods of use therefor
AU2002220419A1 (en) Prolamin-based sustained-release compositions and delayed-onset compositions
AU2001275918A1 (en) Biocide compositions and methods and systems employing same
AU2001243394A1 (en) Compounds and methods
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001292047A1 (en) Composition containing an azaphthalocyanine and use
AU2001232930A1 (en) Find and dial
AU2001263270A1 (en) Imaging-offset compensation methods and systems
AU2001229439A1 (en) Bioconjugates and uses thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001233932A1 (en) Method and composition
AU2001233086A1 (en) Ceramidase compositions and methods based thereon